Gold Mini Futures (MCX) (MMI)

La cadena de opciones muestra datos clave de las opciones de acciones de Marcus & Millichap a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Marcus & Millichap..

Marcus & Millichap (NYSE:MMI) Bolsa, Cadena de Opciones

Marcus & Millichap

Marcus & Millichap Inc is a leading national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.

Marcus & Millichap Inc

Metro Mining Ltd

NYLI MacKay Muni Insured ETF

MARMION INDUS CORP by Marmion Industries Corp.

Marmion Industries Corp

MedMira Inc

NYLI MacKay Muni Intermediate ETF

<p>Marcus &amp; Millichap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>) is preparing to release its quarterly earnings on Friday, 2024-11-08. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Marcus &amp; Millichap to report an <strong>earnings per share</strong> (EPS) of $-0.19.</p>
<p>Marcus &amp; Millichap bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Earnings History Snapshot</h3>
<p>Last quarter the company beat EPS by $0.01, which was followed by a 1.56% increase in the share price the next day.</p>
<p>Here's a look at Marcus &amp; Millichap's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.15</td>
<td>-0.28</td>
<td>-0.28</td>
<td>-0.26</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.14</td>
<td>-0.26</td>
<td>-0.27</td>
<td>-0.24</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>2.0%</td>
<td>2.0%</td>
<td>-1.0%</td>
<td>7.000000000000001%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1730995848_0.png" alt="eps graph" /></p>
<h3>Marcus &amp; Millichap Share Price Analysis</h3>
<p>Shares of Marcus &amp; Millichap were trading at $40.27 as of November 06. Over the last 52-week period, shares are up 36.17%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<h3>Analyst Insights on Marcus &amp; Millichap</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Marcus &amp; Millichap.</p>
<p>The consensus rating for Marcus &amp; Millichap is Underperform, derived from 1 analyst ratings. An average one-year price target of $30.0 implies a potential 25.5% downside.</p>
<h3>Peer Ratings Comparison</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of RE/MAX Hldgs, Offerpad Solutions and Fathom Holdings, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for RE/MAX Hldgs, with an average 1-year price target of $10.5, suggesting a potential 73.93% downside.</li>
<li>For Offerpad Solutions, analysts project an Neutral trajectory, with an average 1-year price target of $3.08, indicating a potential 92.35% downside.</li>
<li>As per analysts' assessments, Fathom Holdings is favoring an Outperform trajectory, with an average 1-year price target of $2.5, suggesting a potential 93.79% downside.</li>
</ul>
<h3>Comprehensive Peer Analysis Summary</h3>
<p>The peer analysis summary outlines pivotal metrics for RE/MAX Hldgs, Offerpad Solutions and Fathom Holdings, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Marcus &amp; Millichap</td>
<td>Underperform</td>
<td>-2.76%</td>
<td>$60.29M</td>
<td>-0.88%</td>
</tr>
<tr>
<td>RE/MAX Hldgs</td>
<td>Neutral</td>
<td>-3.38%</td>
<td>$58.38M</td>
<td>0.23%</td>
</tr>
<tr>
<td>Offerpad Solutions</td>
<td>Neutral</td>
<td>-11.17%</td>
<td>$17.14M</td>
<td>-19.03%</td>
</tr>
<tr>
<td>Fathom Holdings</td>
<td>Outperform</td>
<td>-10.87%</td>
<td>$11.16M</td>
<td>-2.46%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Marcus &amp; Millichap ranks at the top for Revenue Growth and Gross Profit among its peers. However, it ranks at the bottom for Return on Equity.</p>
<h3>Discovering Marcus &amp; Millichap: A Closer Look</h3>
<p>Marcus &amp; Millichap Inc is a leading national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.</p>
<h3>Financial Insights: Marcus &amp; Millichap</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Challenges:</strong> Marcus &amp; Millichap's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately <strong>-2.76%</strong>. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Real Estate sector.</p>
<p><strong>Net Margin:</strong> Marcus &amp; Millichap's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of <strong>-3.5%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Marcus &amp; Millichap's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>-0.88%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Marcus &amp; Millichap's ROA excels beyond industry benchmarks, reaching <strong>-0.67%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Marcus &amp; Millichap's debt-to-equity ratio is below the industry average. With a ratio of <b>0.14</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<p><a href="https://www.benzinga.com/quote/MMI/earnings"><strong>To track all earnings releases for Marcus &amp; Millichap visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

Marcus & Millichap's Earnings: A Preview

<p>&quot;During this period of market uncertainty, we successfully connected multiple buyers with their respective lenders to fulfill the portfolio closing requirements for the seller, with minimal contingencies and securing non-refundable earnest money,&quot; said Ebrahim Valliani, first vice president investments in Marcus &amp; Millichap&#39;s Chicago Oak Brook office. &quot;We delivered the confidence that the sellers needed for a successful and reliable transaction.&quot; Valliani represented the seller, Skyline Investments Inc., and procured the buyers, with support from Chris Gomes, Allan Miller and Michael Klar of the Miller-Gomes Hotel Team of Marcus &amp; Millichap.</p>


News

Reported Earlier, Marcus & Millichap Closes $101M Sale Of 11-Property Courtyard Hotel Portfolio Across Seven U.S. States

Reported Earlier, Marcus & Millichap Closes $187.5M Deal For 497-Unit Multifamily Phoenix Property

<p>Wells Fargo  analyst Blaine Heck   maintains Marcus &amp; Millichap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>) with a Underweight and raises the price target from $20 to $30.</p>


Price Target

Analyst Ratings

Wells Fargo Maintains Underweight on Marcus & Millichap, Raises Price Target to $30

<p>Marcus &amp; Millichap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.15) by 6.67 percent. This is a 39.13 percent increase over losses of $(0.23) per share from the same period last year.  The company reported quarterly sales of $158.37 million which missed the analyst consensus estimate of $160.70 million by 1.45 percent.  This is a 2.76 percent decrease over sales of $162.87 million the same period last year.</p>


Earnings Beats

Earnings Misses

Marcus & Millichap Q2 GAAP EPS $(0.14) Beats $(0.15) Estimate, Sales $158.37M Miss $160.70M Estimate

<p><a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.institutionalpropertyadvisors.com%2F&amp;esheet=54038247&amp;newsitemid=20240606951680&amp;lan=en-US&amp;anchor=IPA+Capital+Markets&amp;index=1&amp;md5=2b133f780cc6d88da52ea366abc39c1f">IPA Capital Markets</a>, a division of&nbsp;<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.marcusmillichap.com%2F&amp;esheet=54038247&amp;newsitemid=20240606951680&amp;lan=en-US&amp;anchor=Marcus+%26amp%3B+Millichap+%28NYSE%3AMMI%29&amp;index=2&amp;md5=b2e5c71653f52015d1fe3dd5fc153f21">Marcus &amp; Millichap (NYSE:</a><a href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>), specializing in capital markets services for major private and institutional clients, announced the&nbsp;$72.24 million&nbsp;refinance of La Vista City Centre, a growing master-planned multifamily, office and retail development in La Vista, Nebraska.</p>
<p>Frank Montalto, IPA Capital Markets managing director based in the firm&#39;s Chicago office, secured the financing on behalf of City+Ventures, a Nebraska-based investment and development company that partnered with the City of La Vista beginning in 2015 for the development of the community.</p>


Reported Earlier, Marcus & Millichap's IPA Division Secures $72M For Refinancing Omaha's La Vista City Centre

<p>Marcus &amp; Millichap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.28) by 7.14 percent. This is a 73.33 percent decrease over losses of $(0.15) per share from the same period last year.  The company reported quarterly sales of $129.10 million which beat the analyst consensus estimate of $127.50 million by 1.26 percent.  This is a 16.60 percent decrease over sales of $154.79 million the same period last year.</p>


Marcus & Millichap Q1 GAAP EPS $(0.26) Beats $(0.28) Estimate, Sales $129.10M Beat $127.50M Estimate

<p>Institutional Property Advisors (IPA), a division of Marcus &amp; Millichap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>), announced today the sale and financing of Alta Chandler at The Park, a 291-unit mid-rise multifamily asset in Chandler, Arizona. The property traded for&nbsp;$94.5 million, which represents&nbsp;$324,742&nbsp;per unit. IPA Capital Markets arranged&nbsp;$52 million&nbsp;in acquisition financing.</p>


Reported Earlier, Marcus & Millichap's Institutional Property Advisors Brokers Sale And Arranges Financing For $94.5M Southeast Phoenix Multifamily Asset

<p>The company said, notwithstanding the ongoing price discovery and wider than normal bid/ask spreads, the commercial real estate transaction market is poised over the long-term to overcome the near term challenges which are currently expected to extend for the first half of 2024.</p>


Guidance

Marcus & Millichap Says It Remains Well-positioned To Achieve Long-term Growth

<p>Marcus &amp; Millichap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.28) by 3.57 percent. This is a 235 percent decrease over earnings of $0.20 per share from the same period last year.  The company reported quarterly sales of $166.24 million which missed the analyst consensus estimate of $171.20 million by 2.90 percent.  This is a 36.66 percent decrease over sales of $262.45 million the same period last year.</p>


Marcus & Millichap Q4 EPS $(0.27) Beats $(0.28) Estimate, Sales $166.24M Miss $171.20M Estimate

<p><strong>Marcus &amp; Millichap</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>) is set to give its latest quarterly earnings report on Friday, 2024-02-16. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Marcus &amp; Millichap will report an <strong>earnings per share</strong> (EPS) of $-0.28. </p>
<p>Marcus &amp; Millichap bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Historical Earnings Performance</h3>
<p>Last quarter the company beat EPS by $0.02, which was followed by a 0.0% drop in the share price the next day.</p>
<p>Here's a look at Marcus &amp; Millichap's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2023</strong></th>
<th><strong>Q2 2023</strong></th>
<th><strong>Q1 2023</strong></th>
<th><strong>Q4 2022</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.26</td>
<td>-0.23</td>
<td>-0.17</td>
<td>0.19</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.24</td>
<td>-0.23</td>
<td>-0.15</td>
<td>0.20</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>7.01%</td>
<td>-1.53%</td>
<td>1.69%</td>
<td>1.59%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1708009233_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Marcus &amp; Millichap were trading at $38.61 as of February 14. Over the last 52-week period, shares are up 12.51%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/MMI/earnings"><strong>To track all earnings releases for Marcus &amp; Millichap visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Marcus & Millichap Earnings Preview

<p>Marcus &amp; Millichap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>), a leading commercial real estate brokerage firm specializing in investment sales, financing, research and advisory services, announced today the sale of Alta Cooley Station, a 248-unit, mid-rise multifamily property in Cooley Station, an upscale master-planned community in Gilbert, Arizona. The asset traded for&nbsp;$80 million, which equates to&nbsp;$322,581&nbsp;per uni</p>


Marcus & Millichap's Institutional Property Advisors Closed A $80M Multifamily Asset Sale In Gilbert, Arizona

Reported Earlier, Marcus & Millichap Enters Strategic Partnership With EquityMultiple

Marcus & Millichap Enters Strategic Partnership That Includes An Equity Investment And Commercial Relationship With Real Estate Technology Firm Archer

<p>Marcus &amp; Millichap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.26) by 7.69 percent. This is a 145.28 percent decrease over earnings of $0.53 per share from the same period last year.  The company reported quarterly sales of $162.03 million which missed the analyst consensus estimate of $164.80 million by 1.68 percent.  This is a 49.97 percent decrease over sales of $323.84 million the same period last year.</p>


Marcus & Millichap Q3 EPS $(0.24) Beats $(0.26) Estimate, Sales $162.03M Miss $164.80M Estimate

<p><strong>Marcus &amp; Millichap</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>) is set to give its latest quarterly earnings report on Friday, 2023-11-03. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that Marcus &amp; Millichap will report an <strong>earnings per share</strong> (EPS) of $-0.26. </p>
<p>Marcus &amp; Millichap bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Historical Earnings Performance</h3>
<p>Last quarter the company missed EPS by $0.00, which was followed by a 0.0% drop in the share price the next day.</p>
<p>Here's a look at Marcus &amp; Millichap's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2023</strong></th>
<th><strong>Q1 2023</strong></th>
<th><strong>Q4 2022</strong></th>
<th><strong>Q3 2022</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.23</td>
<td>-0.17</td>
<td>0.19</td>
<td>0.55</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.23</td>
<td>-0.15</td>
<td>0.20</td>
<td>0.53</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-1.53%</td>
<td>1.69%</td>
<td>1.59%</td>
<td>0.38%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2023/1698940925_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Marcus &amp; Millichap were trading at $29.22 as of November 01. Over the last 52-week period, shares are down 13.9%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/MMI/earnings"><strong>To track all earnings releases for Marcus &amp; Millichap visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Preview: Marcus & Millichap

Marcus & Millichap's Institutional Property Advisors Closed A $106.65M Multifamily Asset Sale In California's San Fernando Valley

Marcus & Millichap's Military Bridge To Brokerage Spearheads Legislation To Help Veterans

<p><a href="https://www.marcusmillichap.com/news-events/press/2023/10/10-19-fairfield-inn-salem">https://www.marcusmillichap.com/news-events/press/2023/10/10-19-fairfield-inn-salem</a></p>
<p>Marcus &amp; Millichap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>), a leading commercial real estate brokerage firm specializing in investment sales, financing, research and advisory services, announced today the sale of a Fairfield Inn &amp; Suites located in Salem, Virginia. The property sold for an undisclosed price.<br /><br />Chase Dewese, Jack Davis and Joce Messinger, investment specialists with the DDM Hotel Group of Marcus &amp; Millichap, procured the buyer on behalf of the developer, Kaylan Hospitality. Brian Hosey assisted in the transaction as Virginia broker of record.<br /><br />"We were able to engage an out-of-state buyer looking to expand his asset portfolio in the western Virginia market," says Dewese. "Kaylan Hospitality, one of the well-known developers in the region, delivered an exceptional product."<br /><br />"Our team continues to perform and uncover value in the southeast, even during this period of economic uncertainty," adds Davis.&nbsp;<br /><br />The hotel is located at 121 Sheraton Drive in Salem. Featuring 113 guest rooms, it was built on 3.13 acres in 2017.&nbsp;</p>


Asset Sales

Marcus & Millichap Inc Announces Sale Of Fairfield Inn & Suites In Salem; No Financial Terms Disclosed

<p>Waters Edge, a 304-unit multifamily asset located in The Lakes master-planned community, consisting of high-end waterfront single-family residences, condos, and apartments in Kent, Washington. The property sold for&nbsp;$80 million, or&nbsp;$263,125&nbsp;per unit.</p>


Marcus & Millicha's Institutional Property Advisors Brokers $80M Puget Sound Multifamily Asset Sale

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>The end of the pandemic served as a springboard for the economy, launching us into a new bull market. I can&rsquo;t blame people for being optimistic after seeing the meteoric rise of several big-name stocks. AI continues to dominate tech, carrying the rest of the sectors. As a direct result, the <a href="https://www.cnbc.com/2024/07/09/stock-market-today-live-updates.html"><strong>S&amp;P 500</strong> closed above $5,600 for the first time</a>. So that&rsquo;s the good news. However, even in this market condition, savvy investors should be on the lookout for stocks to sell now.</p>



<p>This brings us to the bad news. Unfortunately, bull markets can&rsquo;t do much for companies already struggling to keep their heads above the water. Warning signs include deteriorating financial conditions, unflattering Wall Street ratings and bleak prospects. All these point to a downward spiral, and prudent investors might want to jump ship to keep their portfolios intact.&nbsp;</p>



<p>To come up the list of stocks to sell now, I screened for the following criteria:&nbsp;</p>



<ul><li>Must have a sell, underperform or strong sell rating from analysts,</li>



<li>Negative YOY revenue growth on its latest annual report,</li>



<li>Negative YOY earnings growth on its latest annual report.</li>
</ul><p>Then, I arranged the stocks from highest to lowest revenue percentage loss. Here are the results:</p>



<h2>Marcus &amp; Millichap (MMI)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/01/real-estate-stocks-keys-city-1600-300x169.jpg" alt="hand of person in a suit dangling keys with a house symbol on the ring. Windows overlooking city skyline in background."><div>Source: ImageFlow/shutterstock.com</div></div><p><strong>Marcus &amp; Millichap</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/mmi-stock-quote/"><strong>MMI</strong></a></span>) is a brokerage firm specializing in commercial real estate sales, research, advisory and financing services.<strong> </strong>It operates in four main commercial real estate business segments:</p>



<ul><li>Properties&nbsp;</li>



<li>Middle market</li>



<li>Private client market</li>



<li>Larger transaction market.</li>
</ul><p>The company serves its clients with different types of property portfolios that match their needs, helping to maximize their value while securing competitive financing from lenders. Marcus &amp; Millichap also caters to the private market through its investment brokerage and financing.&nbsp;</p>



<p>Marcus &amp; Millichap had a rough 2023. <a href="https://ir.marcusmillichap.com/news-events/press-releases/detail/342/marcus-millichap-inc-reports-results-for-fourth-quarter">President and CEO Hessam Nadji</a> states that the &ldquo;ongoing market disruption created by the Fed&rsquo;s fight against inflation and persistent interest rate volatility impacting real estate valuations&rdquo; negatively impacts the company&rsquo;s performance.&nbsp;</p>



<p>So, let&rsquo;s get into the gory details. FY 2023&rsquo;s revenue is down a full 50.4% YOY, reflected evenly across all its revenue sources. The year ended with a $0.88 net loss per share, compared to FY 2022&rsquo;s $2.59 profit.&nbsp;</p>



<p>Nadji states that the company is focused on maintaining a strong balance sheet and improving client relations. However, analysts aren&rsquo;t impressed with the news; MMI stock currently <a href="https://www.nasdaq.com/market-activity/stocks/mmi/analyst-research">has a sell rating</a>, which might be a good enough reason to tack MMI on your list of stocks to sell now.&nbsp;</p>



<h2>Medifast (MED)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/07/healthcare-1600-300x169.jpg" alt="Nurse holding a tablet with icons representing different aspects of healthcare and healthcare data representing CANO stock. Healthcare Tech Stocks. Healthcare Stocks to Buy"><div>Source: metamorworks / Shutterstock</div></div><p>Known for being the parent company of OPTAVIA, one of the fastest-growing health and wellness communities, <strong>Medifast </strong>(NYSE:<span><a href="https://investorplace.com/stock-quotes/med-stock-quote/"><strong>MED</strong></a></span>) provides a comprehensive approach to achieving lasting optimal health and well-being through clinically proven health benefits and evidence-based tools. These tools include a habit-creation framework guided by its independent coaches and supportive community.</p>



<p>The company also provides access to board-certified affiliated clinicians and medications that help treat obesity and other health conditions.</p>



<p>Medifast&rsquo;s FY 2023 report painted quite a bleak picture for the company. Revenue is down 32.9% YOY to $1.1 billion. The bottom line is no better, dropping from $12.73 per diluted share in FY 2022 to $9.10. Even on a non-GAAP basis, EPS is still 33.5% lower YOY.&nbsp;</p>



<p>&ldquo;We are realigning our business to respond to the evolving dynamics of the weight loss industry and to aggressively execute on bold initiatives to transform our business model,&rdquo; said <a href="https://ir.medifastinc.com/2024-02-20-Medifast-Announces-Fourth-Quarter-and-Full-Year-2023-Financial-Results">Chairman and CEO Dan Chard</a>.&nbsp;</p>



<p>Analysts maintain MED stock an &ldquo;<a href="https://www.nasdaq.com/market-activity/stocks/med/analyst-research">underperform</a>&rdquo; rating until things turn around. So when exactly is that?&nbsp;</p>



<p>&ldquo;This remains a challenging market,&rdquo; says Chard, &ldquo;and it will take time to navigate the transformational path that we are on.&rdquo;</p>



<p>In the meantime, investors holding onto Medifast stock might want to sell the stock and shop around for better prospects.</p>



<h2>Worthington Enterprises (WOR)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/03/manufacturing-1600-300x169.jpg" alt="Male and Female Industrial Engineers in Hard Hats Discuss New Project while Using Laptop. They Make Showing Gestures.They Work in a Heavy Industry Manufacturing Factory. manufacturing stocks"><div>Source: Gorodenkoff via Shutterstock</div></div><p><strong>Worthington Enterprises</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/wor-stock-quote/"><strong>WOR</strong></a></span>) is a diversified manufacturing company that operates into two main business segments:</p>



<ul><li><strong>Consumer products</strong>: tools, celebrations and outdoor living products.</li>



<li><strong>Building products</strong>: heating, water and cooling solutions.</li>
</ul><p>Worthington Enterprises is known for its focus on providing value-added steel processing and manufacturing. The company&rsquo;s product brand portfolio includes Coleman, Garden-Weasel, PowerCore and HALO. It also operates in lightweight, customizable LPG composite cylinders.&nbsp;</p>



<p>Worthington recently announced its FY 2024 results &mdash; and, in case you hadn&rsquo;t guessed, it&rsquo;s not pretty. Net sales dropped from $1.42 billion to $1.25 billion, a 12% decrease. While expenses were down for the year, the report still recorded a <a href="https://ir.worthingtonenterprises.com/news/news-details/2024/Worthington-Enterprises-Reports-Fourth-Quarter-Fiscal-2024-Results/default.aspx">$73.5 million operating loss</a>.&nbsp;</p>



<p>The company <em>was</em> profitable in FY 2024, but diluted EPS decreased from $5.19 to $2.20. While management is cautiously optimistic, analysts still rate WOR stock an &ldquo;<a href="https://www.nasdaq.com/market-activity/stocks/wor/analyst-research">underperform</a>.&rdquo; If you&rsquo;re holding on to the company, maybe it&rsquo;s time to consider WOR as an option in stocks to sell.&nbsp;</p>



<p><em>On the date of publication, Rick Orford did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com </em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/"><em>Publishing Guidelines</em></a>.</p>



<p><em>On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.</em></p>
<div><p>Rick Orford is a Wall Street Journal best-selling author, investor, influencer, and mentor. His work has appeared in the most authoritative publications, including Good Morning America, Washington Post, Yahoo Finance, MSN, Business Insider, NBC, FOX, CBS, and ABC News.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/07/time-to-unload-3-stocks-in-deep-trouble-to-sell-now/">Time to Unload: 3 Stocks in Deep Trouble to Sell Now</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Time to Unload: 3 Stocks in Deep Trouble to Sell Now

Marcus & Millichap declares $0.25 dividend

Institutional Property Advisors announces sale of Marlowe Grapevine property

Marcus &amp; Millichap GAAP EPS of -$0.14, revenue of $158.37M

Marcus & Millichap, Inc. 2024 Q2 - Results - Earnings Call Presentation

Marcus & Millichap, Inc. (MMI) Q2 2024 Earnings Call Transcript

Analyst Blaine Heck of Wells Fargo maintained a Sell rating on Marcus & Millichap (MMI – Research Report), retaining the price target of $20.00. Bl...

Sell Rating on Marcus & Millichap Amidst Market Volatility and Financial Uncertainties

In a report released today, Ike Boruchow from Wells Fargo maintained a Sell rating on Marcus & Millichap (MMI – Research Report), with a price targ...

Wells Fargo Sticks to Their Sell Rating for Marcus & Millichap (MMI)

Blaine Heck, an analyst from Wells Fargo, maintained the Sell rating on Marcus & Millichap (MMI – Research Report). The associated price target rem...

Underweight Rating on Marcus & Millichap: Financing Woes and Sluggish Recovery Impact Outlook

Warning: MMI is at high risk of performing badly

Press Releases

Marcus & Millichap's IPA Capital Markets Announces Strategic Hire of Industry Veteran in Dallas

Marcus & Millichap's Institutional Property Advisors Closes $187.5 Million Multifamily Asset Sale in Phoenix

Marcus & Millichap Brokers Record-Breaking Manufactured Housing Asset Sale in Malibu

Marcus & Millichap's IPA Capital Markets Arranges $75 Million Financing for Midtown Manhattan Office-to-Residential Conversion Project

Marcus & Millichap's Institutional Property Advisors Brokers Sale of Grocery-Anchored Regional Power Center in Central New Jersey

Institutional Property Advisors Brokers $92.5 Million Multifamily Sale in L.A.'s NoHo Arts District

Marcus & Millichap, Inc. to Report Third Quarter 2024 Financial Results on Friday, November 8, 2024

Marcus & Millichap Closes $101 Million 11-Property Hospitality Portfolio Sale

Marcus & Millichap's IPA Capital Markets Arranges $110 Million in Agency Financing and Joint Venture Partnership for Connecticut Multifamily Acquisition

Marcus & Millichap's IPA Capital Markets Arranges $63 Million Multifamily Refinance in Greater Austin

Altisource Portfolio Solutions S.A. - Common Stock

Altisource Portfolio

KE Holdings Inc American Depositary Shares (each representing three Class A Ordinary Shares)

Comments

Marcus & Millichap

Marcus & Millichap (MMI) Opciones

Marcus & Millichap (NYSE:MMI) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL